Diagnostic Pathology · 2014 · 11 citations · 7 references
MedicineNuclear MedicineOncologyCardiac Nuclear MedicineMolecular ImagingTumor PathologyBiomarkers In Cardio-oncologyCardiac ImagingCardiac Nuclear ImagingCardiovascular PathologyTumor Imaging18F-fluorodeoxyglucose Imaging18F-fluorodeoxyglucose Positron Emission TomographyCardiac Imaging In Cardio-oncologyCardiac Pet ImagingPositron Emission Tomography Detection
Cardiac tumours are relatively rare and are difficult to diagnose merely with imaging techniques. We demonstrated an unusual case of left atrial myxoma, displaying the successful detection by positron emission tomography using 2-deoxy-2-[18 F] fluoro-D-glucose (18 F-FDG PET), correlated closely to more intense and enhanced immunoreactivity with glucose transporter-1 (GLUT-1) in a substantial number of cardiac myxoma cells. Further prospective studies are needed to validate the significance of 18 F-FDG PET findings for cardiac myxoma and the association with immunohistochemical GLUT-1 expression in its tumour cells, after collecting and investigating a larger number of surgical cases examined with both of them. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2991481941253449.
7
Otto Warbürg · Science · 1956 · 13.3K citations
Images in Cardiovascular Medicine
Wilderness and Environmental Medicine · 2012 · 1.5K citations
Medicine, Cardiology, Radiology +11
Hideshi Miyakita, MASATOSI TOKUNAGA, Hajime Onda et al. · International Journal of Urology · 2002 · 116 citations
Medicine, Nuclear Medicine, Oncology +17
Detection of Cardiac Myxoma by F-18 FDG PET
Denis Agostini, Gérard Babatasi, F Galateau et al. · Clinical Nuclear Medicine · 1999 · 49 citations